Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
37 NC counties are under alert, including Johnston and Chatham counties.
Closings
1 closing/delay reported.
Just In
At least 1 death in Buncombe County from Helene, western NC official says
Just In
Storm caused deaths in five states, millions to lose power and record rainfall
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
47.32
+0.83 (+1.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crispr Therapeutics Ag
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
29
30
Next >
Is CRISPR Therapeutics a Buy?
December 08, 2022
A strong cash position could offset some of the near-term risks that come with owning the biotech.
Via
The Motley Fool
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
December 08, 2022
-Clinical Data Due Next Week at ASH-
Via
Benzinga
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
December 08, 2022
These biotech players beat the bear market this year.
Via
The Motley Fool
3 Fierce Stocks That Are Screaming Buys in December
December 07, 2022
Here are three winners in the making.
Via
The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
December 06, 2022
The company has already made plenty of investors happy.
Via
The Motley Fool
What 5 Analyst Ratings Have To Say About CRISPR Therapeutics
November 23, 2022
Via
Benzinga
Why Shares of CRISPR Therapeutics Dropped 19.9% in October
November 07, 2022
Several factors weighed on the gene-editing biotech stocks last month.
Via
The Motley Fool
Where CRISPR Therapeutics Stands With Analysts
November 02, 2022
CRISPR Therapeutics (NASDAQ:CRSP) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Bear Market Bargain Hunting: 3 Top Stocks to Buy Before 2023
December 06, 2022
These top players are ripe for recovery -- and long-term growth.
Via
The Motley Fool
3 Growth Stocks That Are Too Cheap to Ignore
December 01, 2022
Overlooking these stocks in the current market could be a mistake.
Via
The Motley Fool
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
November 28, 2022
Here's how Ark Invest's top holdings have performed in 2022.
Via
Investor's Business Daily
2 Stocks Near 52-Week Highs That Could Climb Higher
November 28, 2022
This pair of stocks are bucking the trend and they could climb even higher.
Via
The Motley Fool
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
November 25, 2022
The ARK Invest founder might regret trimming her position in this biotech stock.
Via
The Motley Fool
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
November 23, 2022
Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years.
Via
Benzinga
Where Will Editas Medicine Be in 1 Year?
November 20, 2022
The company could continue lagging the market for a while.
Via
The Motley Fool
2 Growth Stocks That Could Double in 2023
November 17, 2022
Both are lagging the market this year.
Via
The Motley Fool
Crispr Therapeutics Stock: Bull vs. Bear
November 15, 2022
Crispr shares have fallen about 20% so far this year.
Via
The Motley Fool
5 Top Stocks to Buy Before 2023
November 15, 2022
These stocks have what it takes to win over time.
Via
The Motley Fool
Vertex Pharmaceuticals: Buy at the High?
November 14, 2022
Vertex is submitting a potential blockbuster to regulators this month.
Via
The Motley Fool
Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait a Decade
November 12, 2022
These top stocks could be wise additions to a well-rounded investment portfolio.
Via
The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
November 10, 2022
These healthcare companies haven't been slowed by macroeconomic conditions.
Via
The Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
November 09, 2022
CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 15.41% on an annualized basis producing an average annual return of 23.37%. Currently, CRISPR Therapeutics has a...
Via
Benzinga
3 Healthcare Stocks That Could Go Parabolic
November 09, 2022
These beaten-down stocks are ready for a rebound.
Via
The Motley Fool
Got $1,000? 2 Smart Stocks to Consider Buying Right Now
November 06, 2022
Don't overlook these major healthcare names on your next stock-buying spree.
Via
The Motley Fool
2 Biotech Stocks That Could Make You Richer
November 04, 2022
Both drugmakers are pretty close to their 52-week highs, but that shouldn't stop investors.
Via
The Motley Fool
3 Top Healthcare Stocks to Buy for November
November 04, 2022
Catalysts lie ahead for these promising stocks.
Via
The Motley Fool
What 8 Analyst Ratings Have To Say About CRISPR Therapeutics
November 02, 2022
Within the last quarter, CRISPR Therapeutics (NASDAQ:CRSP) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for CRISPR Therapeutics
November 02, 2022
Over the past 3 months, 8 analysts have published their opinion on CRISPR Therapeutics (NASDAQ:CRSP) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Better Buy: CRISPR Therapeutics vs. Bluebird Bio
October 27, 2022
These two companies have performed almost equally poorly on the stock market in the past year.
Via
The Motley Fool
2 Monster Stocks to Buy Without Any Hesitation
October 26, 2022
These stocks are crushing the bear market.
Via
The Motley Fool
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.